Supplemental material
Gynecological Endocrinology
Volume 35, 2019 - Issue 11
CONSERVATIVE TREATMENT IN DIABETES MELLITUS ENDOMETRIAL HYPERPLASIA AND EARLY ENDOMETRIAL CANCER
Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
, , 
, , , , , , & show all
Gabriele SacconeObstetrics and Gynecology Unit, Department of Neuroscience, Reproductive Sciences and Dentistry, School of Medicine, University of Naples Federico II, Naples, Italy; http://orcid.org/0000-0003-0078-2113
http://orcid.org/0000-0003-0078-2113, , , , , , & show all
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related Research Data
Measurement of endometrial thickness by transvaginal ultrasonography to predict pathological response to medroxyprogesterone acetate in patients with grade 1 endometrioid adenocarcinoma
Source:
Spandidos Publications
Predictors of resolution of complex atypical hyperplasia or grade 1 endometrial adenocarcinoma in premenopausal women treated with progestin therapy
Source:
Elsevier BV
Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012
Source:
American Medical Association (AMA)
Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
Source:
Elsevier BV
Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
Source:
Taylor & Francis
Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia
Source:
Elsevier BV
Insulin and insulin-like growth factor signalling in neoplasia
Source:
Springer Nature
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
Source:
Oxford University Press (OUP)
Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis
Source:
Elsevier BV
Biomarkers of progestin therapy resistance and endometrial hyperplasia progression
Source:
Elsevier BV
Prediction of Regression and Relapse of Endometrial Hyperplasia With Conservative Therapy
Source:
Ovid Technologies (Wolters Kluwer Health)
Diabetes mellitus and responsiveness of endometrial hyperplasia and early endometrial cancer to conservative treatment
Source:
Taylor & Francis
Body mass index and the risk of cancer incidence in patients with type 2 diabetes in Japan: Results from the National Center Diabetes Database
Source:
Wiley-Blackwell
Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis
Source:
Elsevier BV
Methodological index for non-randomized studies
Source:
Wiley
Association of endometrial hyperplasia and cancer with a history of gestational diabetes
Source:
Springer Nature
Endometrial cancer and obesity: Epidemiology, biomarkers, prevention and survivorship
Source:
Elsevier BV
Subcutaneous Progesterone for Endometrial Polyps in Premenopausal Women: A Preliminary Retrospective Analysis
Source:
Elsevier BV
Levonorgestrel-Releasing Intrauterine Systems Versus Oral Cyclic Medroxyprogesterone Acetate in Endometrial Hyperplasia Therapy: A Meta-Analysis
Source:
Springer Nature
Immunohistochemical Nuclear Expression of β-Catenin as a Surrogate of CTNNB1 Exon 3 Mutation in Endometrial Cancer
Source:
Oxford University Press (OUP)
Insulin resistance and overweight prolonged fertility-sparing treatment duration in endometrial atypical hyperplasia patients
Source:
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)
Risk factor analysis of coexisting endometrial carcinoma in patients with endometrial hyperplasia: a retrospective observational study of Taiwanese Gynecologic Oncology Group
Source:
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology and Colposcopy (KAMJE)
PTEN as a predictive marker of response to conservative treatment in endometrial hyperplasia and early endometrial cancer. A systematic review and meta-analysis
Source:
Elsevier BV
Prognostic factors of regression and relapse of complex atypical hyperplasia and well-differentiated endometrioid carcinoma with conservative treatment
Source:
Elsevier BV
Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
Source:
Public Library of Science (PLoS)
Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review
Source:
Wiley
Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials
Source:
Elsevier BV
Loss of PTEN expression as diagnostic marker of endometrial precancer: A systematic review and meta-analysis
Source:
Wiley
Prospective evaluation of abnormal glucose metabolism and insulin resistance in patients with atypical endometrial hyperplasia and endometrial cancer
Source:
Springer Nature
Linking provided by
